Charlet JP - Search Results

1

Baseline level and early suppression of serum HCV RNA for predicting sustained complete response to alpha-interferon therapy.

Izopet J, Payen JL, Alric L, Sandres K, Charlet JP, Vinel JP, Duffaut M, Pascal JP, Puel J. Izopet J, et al. Among authors: charlet jp. J Med Virol. 1998 Feb;54(2):86-91. doi: 10.1002/(sici)1096-9071(199802)54:2<86::aid-jmv3>3.0.co;2-k. J Med Virol. 1998. PMID: 9496364

2

Kinetics of HCV viremia in kidney transplant recipients during and after alpha-interferon therapy.

Izopet J, Rostaing L, Ton-That H, Dubois M, Cazabat M, Charlet JP, Sayada C, Duffaut M, Durand D, Puel J. Izopet J, et al. Among authors: charlet jp. Am J Nephrol. 1997;17(5):417-20. doi: 10.1159/000169133. Am J Nephrol. 1997. PMID: 9382158

3

Study of the association between major histocompatibility complex class II genes and the response to interferon alpha in patients with chronic hepatitis C infection.

Alric L, Izopet J, Fort M, Vinel JP, Fontenelle P, Orfila C, Payen JL, Sandres K, Desmorat H, Charlet JP, Duffaut M, Abbal M. Alric L, et al. Among authors: charlet jp. Hum Immunol. 1999 Jun;60(6):516-23. doi: 10.1016/s0198-8859(99)00021-x. Hum Immunol. 1999. PMID: 10408801

4

Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection.

Alric L, Fort M, Izopet J, Vinel JP, Charlet JP, Selves J, Puel J, Pascal JP, Duffaut M, Abbal M. Alric L, et al. Among authors: charlet jp. Gastroenterology. 1997 Nov;113(5):1675-81. doi: 10.1053/gast.1997.v113.pm9352872. Gastroenterology. 1997. PMID: 9352872

5

Study of host- and virus-related factors associated with spontaneous hepatitis C virus clearance.

Alric L, Fort M, Izopet J, Vinel JP, Bureau C, Sandre K, Charlet JP, Beraud M, Abbal M, Duffaut M. Alric L, et al. Among authors: charlet jp. Tissue Antigens. 2000 Aug;56(2):154-8. doi: 10.1034/j.1399-0039.2000.560207.x. Tissue Antigens. 2000. PMID: 11019916

6

Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trial.

Attal M, Huguet F, Rubie H, Huynh A, Charlet JP, Payen JL, Voigt JJ, Brousset P, Selves J, Muller C, et al. Attal M, et al. Among authors: charlet jp. Blood. 1992 Jun 1;79(11):2834-40. Blood. 1992. PMID: 1586733 Free article. Clinical Trial.

7

Ex vivo flow cytometry determination of intracytoplasmic expression of IL-2, IL-6, IFN-gamma, and TNF-alpha in monocytes and T lymphocytes, in chronic hemodialysis patients.

Rostaing L, Peres C, Tkaczuk J, Charlet JP, Bories P, Durand D, Ohayon E, de Préval C, Abbal M. Rostaing L, et al. Among authors: charlet jp. Am J Nephrol. 2000 Jan-Feb;20(1):18-26. doi: 10.1159/000013550. Am J Nephrol. 2000. PMID: 10644863

8

Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline: a prospective, randomized trial.

Attal M, Huguet F, Rubie H, Charlet JP, Schlaifer D, Huynh A, Laurent G, Pris J. Attal M, et al. Among authors: charlet jp. Blood. 1993 Aug 1;82(3):732-6. Blood. 1993. PMID: 8338943 Free article. Clinical Trial.

9

Discovery of unsuspected pathological states using a new haematology analyser.

Corberand JX, Laharrague PF, Fillola G, Charlet JP, Cambus JP. Corberand JX, et al. Among authors: charlet jp. Med Lab Sci. 1991 Jan;48(1):80-3. Med Lab Sci. 1991. PMID: 2062187

10

Sensorineural hearing loss and otosclerosis: a clinical and radiologic survey of 437 cases.

Shin YJ, Fraysse B, Deguine O, Cognard C, Charlet JP, Sévely A. Shin YJ, et al. Among authors: charlet jp. Acta Otolaryngol. 2001 Jan;121(2):200-4. doi: 10.1080/000164801300043505. Acta Otolaryngol. 2001. PMID: 11349779

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters